Berberine Inhibits the Metastatic Ability of Prostate Cancer Cells by Suppressing Epithelial-to-Mesenchymal Transition (EMT)-Associated Genes with Predictive and Prognostic Relevance

Background: Over 70% of cancer metastasis from prostate cancer develops bone metastases that are not sensitive to hormonal therapy, radiation therapy, or chemotherapy. The epithelial-to-mesenchymal transition (EMT) genetic program is implicated as a significant contributor to prostate cancer progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chia-Hung, Tang, Wan-Chun, Sia, Peik, Huang, Chi-Chen, Yang, Pei-Ming, Wu, Ming-Heng, Lai, I-Lu, Lee, Kuen-Haur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278877/
https://www.ncbi.nlm.nih.gov/pubmed/25552920
http://dx.doi.org/10.7150/ijms.9982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278877/
https://www.ncbi.nlm.nih.gov/pubmed/25552920
http://dx.doi.org/10.7150/ijms.9982

Ejemplares similares